Imagine a company finishing its quarterly report. The accounts have been checked, but the business update says a financing is complete when the agreement has not even been signed. The file may be ready to upload. It is not ready to publish.
An OTCIQ disclosure review needs to cover more than the numbers. Management should know which rules apply, what the officers are signing and whether the report accurately describes what has happened. The board may also have decisions to make. The aim is to resolve those questions before investors read the document.
Which disclosure rules apply to the company?
OTCIQ is the portal companies use to publish reports and manage company information. It is not a reporting category. The OTCIQ disclosure requirements depend on the company's market and reporting standard. These determine which reports, financial statements and certifications it needs.
An SEC-reporting company continues to make its required filings on EDGAR, the SEC's filing system. Publishing a document through OTCIQ does not replace that obligation. Eligible Alternative Reporting companies use OTC Markets' disclosure guidelines. Banks and international companies have their own reporting routes.
Start by identifying the rules for this company and this report. A template used by another issuer may contain the wrong questions or omit a required statement. Likewise, having an OTCIQ account does not mean that every document the company needs can be filed there. OTC Markets' ongoing disclosure summary is a useful starting point, alongside the applicable rulebook.
Who must review and approve the disclosure?
Management should confirm the business facts. Finance should check the accounts and supporting figures. Counsel should review the legal disclosures, required approvals and potential inconsistencies. The board or audit committee should address matters within its responsibilities.
These roles can overlap, but they should not be confused. An outside preparer can help draft the report without taking over the company's responsibility for it. OTCID Rule 2(C) expressly places responsibility for the content on the company.
Does every OTCIQ upload need a board vote? Not necessarily. Check the law where the company is incorporated, its charter and bylaws, committee responsibilities and delegated authority. For example, Delaware law generally places management of the company's affairs under the board's direction, but it does not require directors to vote separately on every upload. Other jurisdictions need their own review.
Also separate approval of a transaction from approval of its description. A board may have authorized management to negotiate a loan without approving the final borrowing. Conversely, approving a completed transaction does not establish that the report describes its terms correctly. Confirm both the underlying authority and who can authorize publication of the final document.
What are the officers actually certifying?
Different certifications serve different purposes. Under the OTCQX U.S. and OTCQB Alternative Reporting guidelines, report certifications are made by the chief executive and chief financial officers, or people performing those roles. They address review of the report, material accuracy and fair presentation of the financial information, based on the signer's knowledge.
The separate annual Management Certification covers matters such as reporting status, shell status, beneficial ownership and convertible debt disclosures. Qualifying international reporting companies instead complete the applicable Rule 12g3-2(b) certification.
Before signing, an officer should read the final version and resolve questions with the people responsible for the information. Sending a signature page ahead of the completed report reverses that process. If figures or disclosures change after review, return the revised version to the relevant signatories. Neither an officer's signature nor an OTC Markets certification amounts to SEC approval.
Do the financial statements and share records agree?
Check that the financial statements cover the required periods and contain the necessary statements and notes. Confirm whether an audit is required and whether the report accurately describes its audit status. Do not label unaudited figures as audited simply because an accountant helped prepare them.
Then compare the share disclosures with the transfer agent's records and the company's issuance documents. The transfer agent maintains the company's securities records, but the dates being compared matter.
Suppose the annual report shows 20 million shares outstanding on December 31. A transfer-agent statement shows 22 million on February 28 because the company issued shares in January. The difference may be correct. Check the intervening issuance and disclose it where required; do not change the December figure merely to make both documents match.
Convertible debt needs attention too. This is debt that can become shares. Review the amount outstanding, conversion terms, relevant holders and potential dilution—the reduction in existing shareholders' percentage ownership when more shares are issued. OTC Markets has identified missing noteholder details and incomplete issuance histories as recurring disclosure problems.
A useful final question is whether each significant figure can be traced to a record. Unsupported balances, missing notes and unexplained share movements should go back to the responsible person before sign-off.
Are ownership, control and related-party details complete?
Read the ownership questions carefully. Different forms can use different thresholds and definitions. Do not carry one percentage test across every report, certification and attorney letter.
Check the required details for officers, directors, significant owners, controlling entities and noteholders. Where the instructions call for the people controlling a corporate shareholder, naming only the company is not enough. Ask who actually holds the relevant ownership or control rights.
Transactions with management or connected businesses also need review. The disclosure guidelines address related-party transactions and specified litigation and regulatory history. A loan from a director, for example, should be assessed under the applicable requirements rather than treated as an ordinary outside loan because the paperwork looks similar.
Check shell status and changes in control against current facts, not last year's answers. Under the OTCID rules, a control change can require notice, a new application, an updated profile and a new Management Certification where applicable. Other markets have their own provisions.
Finally, disclosure does not supply a missing corporate approval. Describing a share issuance in a report is not a substitute for establishing that the company validly authorized it.
Could the wording still mislead an investor?
A report can contain accurate figures and still give the wrong impression. Material information is information important to a reasonable investor. Rule 10b-5 prohibits material false statements and omissions that make what has been said misleading in connection with securities purchases or sales.
Consider an acquisition. The company has signed an agreement, but financing and regulatory conditions remain outstanding. Saying it has acquired the business would describe a different position from saying it has agreed to acquire it, subject to those conditions.
Compare the report with public announcements and investor materials. Does a presentation promise revenue that the report describes only as a possibility? Has an earlier announcement said that a deal closed when the latest documents show it did not?
Separate completed events from proposals, expectations and forecasts. A general risk disclaimer does not turn an inaccurate statement into an accurate one. At the same time, the anti-fraud rule is not a universal requirement to announce every development immediately. Separate reporting and market rules may require an announcement.
Does anything need a separate or earlier announcement?
The next quarterly report may be too late for a particular event. Check whether it triggers a current report, prompt public announcement or another notice under the company's reporting route. The OTCQB rules separately address material developments and convertible debt arrangements. Do not assume one deadline covers everything.
Corporate actions need a separate check. A stock split or name change may involve FINRA Rule 6490, supporting documents and advance notification requirements. An OTCIQ announcement does not replace a required FINRA submission.
Also consider who will receive the information before publication. Regulation FD addresses selective disclosure by covered issuers to specified market professionals and shareholders. It does not cover every OTC company; foreign private issuers, for example, are excluded. Where it applies, intentional disclosures generally require simultaneous public disclosure, while unintentional disclosures require prompt public disclosure.
An applicable confidentiality exception may permit a private discussion, but establish that before sharing material nonpublic information. Do not assume that calling someone a prospective investor makes selective disclosure permissible.
What does an attorney letter cover?
First establish whether the company's reporting route requires an attorney letter. It is not a document every issuer needs for every report.
Where required, the attorney-letter guidelines call for review of specified public information and supporting records. They also require meetings and discussions with management and a majority of the directors. Counsel must identify the documents reviewed and their publication dates, address the financial statements and confirm share information using the required checks.
Arrange that work early enough for questions to be resolved. The final letter must correspond to the actual published documents, including relevant amendments, rather than an earlier draft.
The letter is not an audit, a management certification or regulatory approval. It does not cure incomplete disclosures, replace a required audit or guarantee a market designation. The company's factual review and the officers' confirmations remain separate parts of the process.
What should the final approval record contain?
We recommend keeping a short sign-off file for each reporting package. Include the approved report and exhibits, signed certifications, supporting records, any required resolutions or consents, and a note of how material questions were resolved. This is a suggested control, not a universal OTCIQ form or a new retention rule.
Make sure the authorization identifies the final version. Approval of a draft sent on Monday should not be treated as approval of material changes made on Thursday. Keep the accounting and legal reviewers involved when changes affect their work.
Keep confidential supporting documents and privileged legal advice separate from the public package. That does not justify omitting information that must be disclosed. Counsel should help distinguish the disclosure itself from the records and advice supporting it.
This is the practical role of an OTCIQ Disclosure Package: bringing the relevant records and disclosures together so management can address open questions before authorizing publication.
What happens if the report is late or an error is found?
A late report, an incorrect report and a later business development are three different problems. Identify which one has occurred before deciding how to respond.
For a late report, check the applicable notice and extension procedure. OTC Markets' reporting timetable distinguishes the reporting routes. A late-filing notice does not permit inaccurate information, and an OTC filing extension should not be assumed to extend a separate SEC deadline.
For an error, assess its significance promptly. Identify the affected statements and determine whether an amendment, corrective announcement, fresh certification or revised attorney letter is needed. OTC Markets explains that it requests amended disclosures when it identifies incomplete or inconsistent information. Do not assume that quietly replacing a PDF resolves a material misstatement.
A later event may need a new report rather than a correction to something that was accurate when published. A typographical error is not automatically securities fraud either. The response should fit the issue and the applicable requirements.
Disclosure gaps may also affect broker quotations. That separate review is explained in our Rule 15c2-11 guide. Uploading a corrected report is not, by itself, a guarantee of quotation eligibility.
Ongoing OTCIQ Maintenance should keep reports, certifications and company information under review between filing dates. Publication is not the end of the responsibility.
Preparing an OTCIQ report or reviewing an upcoming disclosure? Ishimbayev Law Firm's OTCIQ Disclosure Package and OTCIQ Maintenance services help management check disclosures, resolve legal gaps and coordinate the required review before publication.
This article provides general information about U.S. OTC disclosure requirements reviewed in November 2026. It is not legal or investment advice.
